Product Information
TAMIFLU 6 MG/ML SUSPENSION is a brand product labeled by Genentech, Inc., priced at $2.4329 per ML under NDC 00004082205. Its NADAC has been published 514 times since Nov 28, 2013.
FDA first approved this application on Dec 14, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Oseltamivir Phosphate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6 mg/mL
Manufacturer
Genentech, Inc.NDC
00004082205
Classification
Brand
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA021246FDA Approved
12/14/2000
TE Code
AB
On Market Since
3/21/2011
Pharmacological Classes
Price Statistics
The NADAC for TAMIFLU 6 MG/ML SUSPENSION has been published 514 times since Nov 28, 2013, and over the history we have for it it has risen 42.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.4329 per ML |
|---|---|
| All-time high | $2.4394 (Jan 10, 2024) |
| All-time low | $1.7028 (Nov 28, 2013) |
| 52-week high | $2.4329 |
| 52-week low | $2.4308 |
| Median price | $2.4249 |
| Average price | $2.2957 |
| Largest weekly change | +9.0% (Jul 9, 2014) |
| Weeks tracked | 514 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Genentech, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oseltamivir Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Neuraminidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TAMIFLU 6 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for TAMIFLU 6 MG/ML SUSPENSION, manufactured by Genentech, Inc., is $2.4329 per ML (NDC 00004082205), effective Sep 30, 2026.
How has the price of TAMIFLU 6 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for TAMIFLU 6 MG/ML SUSPENSION has risen 42.9%. It has been tracked across 514 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TAMIFLU 6 MG/ML SUSPENSION?
Since Nov 28, 2013, the NADAC for TAMIFLU 6 MG/ML SUSPENSION has ranged from a low of $1.7028 (Nov 28, 2013) to a high of $2.4394 (Jan 10, 2024), with a median of $2.4249 per ML.
Are there cheaper alternatives to TAMIFLU 6 MG/ML SUSPENSION?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OSELTAMIVIR 6 MG/ML SUSPENSION, is $0.1496 per ML — about 94% below TAMIFLU 6 MG/ML SUSPENSION.
Who manufactures TAMIFLU 6 MG/ML SUSPENSION?
TAMIFLU 6 MG/ML SUSPENSION (NDC 00004082205) is labeled by Genentech, Inc., and CMS classifies it as a brand product.